107 results match your criteria: "Paris Sciences Lettres Research University[Affiliation]"

Exploration into Galectin-3 Driven Endocytosis and Lattices.

Biomolecules

September 2024

Cellular and Chemical Biology Unit, Institut Curie, Paris Sciences & Lettres Research University, U1143 INSERM, UMR3666 CNRS, 75248 Paris, France.

Essentially all plasma membrane proteins are glycosylated, and their activity is regulated by tuning their cell surface dynamics. This is achieved by glycan-binding proteins of the galectin family that either retain glycoproteins within lattices or drive their endocytic uptake via the clathrin-independent glycolipid-lectin (GL-Lect) mechanism. Here, we have used immunofluorescence-based assays to analyze how lattice and GL-Lect mechanisms affect the internalization of the cell adhesion and migration glycoprotein αβ integrin.

View Article and Find Full Text PDF

Background: BRCA1:c.5017_5019del (p.His1673del) is a founder variant relatively frequent in Northern Italy.

View Article and Find Full Text PDF

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.

Am J Hum Genet

September 2024

Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. Electronic address:

Article Synopsis
  • The ENIGMA research consortium focuses on determining the clinical significance of variants in hereditary breast and ovarian cancer genes, specifically BRCA1 and BRCA2, and evolved from an external expert panel to an internal Variant Curation Expert Panel (VCEP) to enhance alignment with FDA recognized classification processes.
  • The VCEP reviewed existing classification criteria and utilized statistical methods to assess evidence strength, testing new specifications on variants and updating documentation for better user clarity.
  • Analysis led to refined classifications for variants—resolving uncertainties and maintaining confidence in others—while revealing gaps in both ENIGMA's research and ACMG/AMP criteria, ultimately improving the classification process for BRCA1 and BRCA2 variants.
View Article and Find Full Text PDF

Psychological and ethical issues raised by genomic in paediatric care pathway, a qualitative analysis with parents and childhood cancer patients.

Eur J Hum Genet

November 2024

UF of Psychology and Liaison and Emergency Psychiatry, DMU Psychiatry and Addictology, Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, F-75015, Paris, France.

In paediatric oncology, genomics raises new ethical, legal and psychological issues, as somatic and constitutional situations intersect throughout the care pathway. The discovery of potential predisposition in this context is sometimes carried out outside the usual framework. This article focuses on the views of children, adolescents, and young adults (AYA) with cancer and their parents about their experience with genomic testing.

View Article and Find Full Text PDF

Background: pathogenic variants (PV) have been recently identified as the most frequent variants predisposing to Sonic Hedgehog (SHH) medulloblastomas (MB); however, guidelines are still lacking for genetic counseling in this new syndrome.

Methods: We retrospectively reviewed clinical and genetic data of a French series of 29 -mutated MB.

Results: All patients developed SHH-MB, with a biallelic inactivation of found in 24 tumors.

View Article and Find Full Text PDF

Toward vanishing droplet friction on repellent surfaces.

Proc Natl Acad Sci U S A

April 2024

Department of Applied Physics, Aalto University, Espoo 02150, Finland.

Superhydrophobic surfaces are often seen as frictionless materials, on which water is highly mobile. Understanding the nature of friction for such water-repellent systems is central to further minimize resistance to motion and energy loss in applications. For slowly moving drops, contact-line friction has been generally considered dominant on slippery superhydrophobic surfaces.

View Article and Find Full Text PDF

The Ataxia-Telangiectasia Mutated gene is implicated in DNA double-strand break repair. Controversies in clinical radiosensitivity remain known for monoallelic carriers of the pathogenic variant (PV). An evaluation of the single-nucleotide polymorphism (SNP) rs1801516 (G-A) showed different results regarding late subcutaneous fibrosis after breast radiation therapy (RT).

View Article and Find Full Text PDF

Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.

Nat Commun

April 2024

Université Paris Cité, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut Cochin, Paris, France.

Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1. Molecular bases of these divergences are poorly understood. Here we find that SF3B1-mutated MDS show reduced R-loop formation predominating in gene bodies associated with intron retention reduction, not found in U2AF1- or SRSF2-mutated MDS.

View Article and Find Full Text PDF

Meningioangiomatosis (MAM) remains a poorly understood lesion responsible for epileptic disease. In the past, MAM was primarily described in the context of neurofibromatosis type 2 before being mainly reported sporadically. Moreover, the malformative or tumoral nature is still debated.

View Article and Find Full Text PDF

Using field observations from a sanctuary, Oña and colleagues (DOI: 10.7717/peerj.7623) investigated the semantics of face-gesture combinations in chimpanzees ().

View Article and Find Full Text PDF

Breast cancers (BC) are rare in men and are often caused by constitutional predisposing factors. In women, mosaic BRCA1 promoter methylations (MBPM) are frequent events, detected in 4-8% of healthy subjects. This constitutional epimutation increases risk of early-onset and triple-negative BC.

View Article and Find Full Text PDF

Background: Monoallelic germline MBD4 pathogenic variants were recently reported to cause a predisposition to uveal melanoma, associated with a specific tumor mutational signature and good response to immunotherapy. Monoallelic tumor pathogenic variants have also been described in brain tumors, breast cancers, and myxofibrosarcomas, whereas biallelic germline MBD4 pathogenic variants have been involved in a recessive hereditary adenomatous polyposis and a specific type of acute myeloid leukemia.

Methods: We analyzed MBD4 for all patients with a diagnosis of uveal melanoma at Institut Curie since July 2021 and in the 3240 consecutive female probands explored at the Institut Curie for suspicion of predisposition to breast cancer between July 2021 and February 2023.

View Article and Find Full Text PDF

The bevacizumab (bev)/olaparib (ola) maintenance regimen was approved for BRCA1/2-mutated (BRCAmut) and Homologous Recombination Deficient (HRD) high-grade Advanced Ovarian Cancer (AOC) first line setting, based on a significantly improved progression-free survival (PFS) compared to bev alone in the PAOLA-1/ENGOT-ov25 trial (NCT02477644), where HRD was detected by MyChoice CDx PLUS test. The academic shallowHRDv2 test was developed based on shallow whole-genome sequencing as an alternative to MyChoice. Analytical and clinical validities of shallowHRDv2 as compared to MyChoice on 449 PAOLA-1 tumor samples are presented.

View Article and Find Full Text PDF

Purpose: Mosaic promoter methylation (meth) increases the risk of early-onset breast cancer, triple-negative breast cancer and ovarian cancer. As mosaic meth are believed to occur de novo, their role in family breast/ovarian cancer has not been assessed.

Patients: Blood-derived DNA from 20 unrelated affected cases from families with aggregation of breast/ovarian cancer, but with no germline pathogenic variants in /, or , were screened by methylation-sensitive high-resolution melting.

View Article and Find Full Text PDF

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling.

Acta Neuropathol Commun

August 2023

Research In Pediatric, Adolescent and Young Adult Oncology, Laboratory of Translationnal Research in Pediatric Oncology, Institut Curie Institute, SIREDO Center Care, INSERM U830, Paris Sciences Lettres Research University, Innovation, Paris, France.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on the role of the MUTYH gene, which codes for a DNA glycosylase that helps prevent certain types of genetic mutations linked to an increased risk of colorectal cancer in individuals with MUTYH-associated polyposis (MAP).
  • - Researchers report a rare case of medulloblastoma in a MAP patient with a specific harmful mutation in the MUTYH gene, using whole exome sequencing to analyze genetic variants and mutational signatures.
  • - Findings show that the medulloblastoma exhibits a mutational pattern associated with MUTYH deficiency, indicating that this type of cancer could potentially be linked to mutations in the MUTYH gene.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists discovered a new type of brain tumor called infant-type hemispheric glioma (IHG) that mostly affects babies.
  • Unlike another brain tumor known as desmoplastic infantile ganglioglioma (DIG/DIA), IHG has different genetic changes, which makes it special.
  • The researchers studied 30 tumors to find differences in how they look and their DNA, and found important characteristics that help distinguish between DIG/DIA and IHG.
View Article and Find Full Text PDF

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer.

Cancer Gene Ther

August 2023

Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.

The tumor suppressor gene WWOX is localized in an unstable chromosomal region and its expression is decreased or absent in several types of cancer. A low expression of WWOX is associated with a poor prognosis in breast cancer (BC). It has recently been shown that WWOX contributes to genome stability through its role in the DNA damage response (DDR).

View Article and Find Full Text PDF

Reuniting philosophy and science to advance cancer research.

Biol Rev Camb Philos Soc

October 2023

CNRS UMR8590, Institut d'Histoire et Philosophie des Sciences et des Technique, University Paris I Panthéon-Sorbonne, 13 rue du Four, Paris, 75006, France.

Cancers rely on multiple, heterogeneous processes at different scales, pertaining to many biomedical fields. Therefore, understanding cancer is necessarily an interdisciplinary task that requires placing specialised experimental and clinical research into a broader conceptual, theoretical, and methodological framework. Without such a framework, oncology will collect piecemeal results, with scant dialogue between the different scientific communities studying cancer.

View Article and Find Full Text PDF

In breast or ovarian cancer (BC/OC) patients with evocative personal and/or family history, multigene panel sequencing is performed on blood to diagnose hereditary predispositions. Additionally, BRCA1/BRCA2 testing can be performed on tumor sample for therapeutic purpose. The accuracy of multigene panel tumor analysis on BC/OC to detect predisposing germline pathogenic variants (gPV) has not been precisely assessed.

View Article and Find Full Text PDF
Article Synopsis
  • Many variants found in disease susceptibility genes are classified as variants of uncertain significance (VUS), making their interpretation critical for clinical decisions.
  • This study introduces a new likelihood ratio-based method that takes into account gene-specific age-related penetrance to better analyze the pathogenicity of these variants.
  • The method outperformed traditional approaches in simulated and real datasets, allowing for clearer classifications of variants as pathogenic or non-pathogenic for conditions like breast cancer, and includes user-friendly tools for researchers.
View Article and Find Full Text PDF

AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.

Genes Chromosomes Cancer

April 2023

Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.

Only a few patients with germline AXIN2 variants and colorectal adenomatous polyposis or cancer have been described, raising questions about the actual contribution of this gene to colorectal cancer (CRC) susceptibility. To assess the clinical relevance for AXIN2 testing in patients suspected of genetic predisposition to CRC, we collected clinical and molecular data from the French Oncogenetics laboratories analyzing AXIN2 in this context. Between 2004 and June 2020, 10 different pathogenic/likely pathogenic AXIN2 variants were identified in 11 unrelated individuals.

View Article and Find Full Text PDF

Premeiotic pairing of homologous chromosomes during male meiosis.

Proc Natl Acad Sci U S A

November 2022

Center for Interdisciplinary Research in Biology, CNRS UMR 7241, INSERM U1050, Collège de France and Paris Sciences & Lettres Research University, 75231 Paris Cedex 05, France.

In the early stages of meiosis, maternal and paternal chromosomes pair with their homologous partner and recombine to ensure exchange of genetic information and proper segregation. These events can vary drastically between species and between males and females of the same species. In in contrast to females, males do not form synaptonemal complexes (SCs), do not recombine, and have no crossing over; yet, males are able to segregate their chromosomes properly.

View Article and Find Full Text PDF